Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Marketing All-Patient Drug Use Results Study for Venetoclax in Japanese Patients With Relapsed and Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Leukemia)

NCT04198415 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT04198415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04198415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Marketing All-Patient Drug Use Results Study for Venetoclax in Japanese Patients With Relapsed and Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Leukemia)
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
February 3, 2020
Completion date
October 21, 2022
Enrollment
4 (actual)
Sites
102

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, chronic lymphocytic leukemia (cll), small lymphocytic leukemia (sll)